US Stock MarketDetailed Quotes

NBSE NeuBase Therapeutics

Watchlist
  • 0.3780
  • 0.00000.00%
Trading May 10 16:00 ET
1.42MMarket Cap-55P/E (TTM)

NeuBase Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
(Q1)Dec 31, 2021
(FY)Sep 30, 2021
(Q4)Sep 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-80.98%1.59M
-62.86%3.69M
4.16M
25.42%33.32M
7.73%7.72M
-5.41%8.36M
68.42%9.93M
56.71%7.3M
55.63%26.57M
40.36%7.17M
Selling and administrative expenses
-66.62%1.2M
-22.30%2.4M
--2.92M
-2.72%11.87M
-33.62%2.24M
3.86%3.6M
13.67%3.09M
11.14%2.94M
20.54%12.2M
34.85%3.37M
-General and administrative expense
-66.62%1.2M
-22.30%2.4M
--2.92M
-2.72%11.87M
-33.62%2.24M
3.86%3.6M
13.67%3.09M
11.14%2.94M
20.54%12.2M
34.85%3.37M
Research and development costs
-91.85%387.56K
-81.21%1.28M
--1.24M
49.33%21.45M
44.39%5.49M
-11.41%4.76M
115.36%6.84M
116.31%4.37M
106.78%14.36M
45.63%3.8M
Operating profit
80.98%-1.59M
62.86%-3.69M
-4.16M
-25.42%-33.32M
-7.73%-7.72M
5.41%-8.36M
-68.42%-9.93M
-56.71%-7.3M
-55.63%-26.57M
-40.36%-7.17M
Net non-operating interest income expense
374.25%162.8K
89,293.80%115.32K
176.02K
729.47%124.51K
964.72%104.02K
3,465.49%34.33K
-95.71%129
-43.42%-13.97K
-157.35%-19.78K
-169.71%-12.03K
Non-operating interest income
338.59%162.92K
3,268.59%116.05K
--178.38K
1,083.71%148.56K
10,260.19%106.71K
1,708.52%37.15K
-63.61%3.45K
--1.25K
--12.55K
--1.03K
Non-operating interest expense
-95.67%122
-77.99%730
--2.35K
-25.62%24.05K
-79.38%2.69K
-8.30%2.82K
-48.67%3.32K
56.30%15.22K
320.63%32.33K
192.80%13.06K
Other net income (expense)
-137.75%-393.33K
2,308.29%125.83K
-111.58K
-149.55%-582.62K
-154.96%-12.52K
-193.34%-165.44K
-98.59%5.23K
-167.78%-409.88K
482.38%1.18M
-94.46%22.79K
Gain on sale of security
--810.9K
--1.43M
----
----
----
----
----
----
309.37%950.15K
-96.95%13.9K
Earnings from equity interest
----
----
----
-85.16%-415.75K
100.00%-3
--0
--0
-1,536.01%-415.74K
14.58%-224.53K
-184.11%-125.78K
Special income (charges)
---1.22M
--0
---6.73K
----
----
----
----
--0
----
----
-Less:Restructuring and merger&acquisition
--365.48K
--0
--6.73K
----
----
----
----
--0
----
----
-Write off
--857.11K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
111.10%18.37K
-25,066.85%-1.3M
---104.85K
-137.06%-166.87K
-109.30%-12.52K
-15,119.60%-165.44K
-98.35%5.23K
--5.86K
10.06%450.31K
--134.67K
Income before tax
78.55%-1.82M
65.27%-3.45M
-4.09M
-32.93%-33.78M
-6.61%-7.63M
1.98%-8.49M
-79.73%-9.92M
-90.06%-7.73M
-46.16%-25.41M
-52.28%-7.16M
Income tax
Net income
78.55%-1.82M
65.27%-3.45M
-4.09M
-32.93%-33.78M
-6.61%-7.63M
1.98%-8.49M
-79.73%-9.92M
-90.06%-7.73M
-46.16%-25.41M
-52.28%-7.16M
Net income continuous Operations
78.55%-1.82M
65.27%-3.45M
---4.09M
-32.93%-33.78M
-6.61%-7.63M
1.98%-8.49M
-79.73%-9.92M
-90.06%-7.73M
-46.16%-25.41M
-52.28%-7.16M
Minority interest income
Net income attributable to the parent company
78.55%-1.82M
65.27%-3.45M
-4.09M
-32.93%-33.78M
-6.61%-7.63M
1.98%-8.49M
-79.73%-9.92M
-90.06%-7.73M
-46.16%-25.41M
-52.28%-7.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
78.55%-1.82M
65.27%-3.45M
-4.09M
-32.93%-33.78M
-6.61%-7.63M
1.98%-8.49M
-79.73%-9.92M
-90.06%-7.73M
-46.16%-25.41M
-52.28%-7.16M
Basic earnings per share
87.31%-0.66
66.00%-2.04
-2.4
-11.83%-20.8
-14.29%-4.8
10.34%-5.2
-25.00%-6
-33.33%-4.8
-4.49%-18.6
-5.00%-4.2
Diluted earnings per share
87.31%-0.66
66.00%-2.04
-2.4
-11.83%-20.8
-14.29%-4.8
10.34%-5.2
-25.00%-6
-33.33%-4.8
-4.49%-18.6
-5.00%-4.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022(Q1)Dec 31, 2021(FY)Sep 30, 2021(Q4)Sep 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -80.98%1.59M-62.86%3.69M4.16M25.42%33.32M7.73%7.72M-5.41%8.36M68.42%9.93M56.71%7.3M55.63%26.57M40.36%7.17M
Selling and administrative expenses -66.62%1.2M-22.30%2.4M--2.92M-2.72%11.87M-33.62%2.24M3.86%3.6M13.67%3.09M11.14%2.94M20.54%12.2M34.85%3.37M
-General and administrative expense -66.62%1.2M-22.30%2.4M--2.92M-2.72%11.87M-33.62%2.24M3.86%3.6M13.67%3.09M11.14%2.94M20.54%12.2M34.85%3.37M
Research and development costs -91.85%387.56K-81.21%1.28M--1.24M49.33%21.45M44.39%5.49M-11.41%4.76M115.36%6.84M116.31%4.37M106.78%14.36M45.63%3.8M
Operating profit 80.98%-1.59M62.86%-3.69M-4.16M-25.42%-33.32M-7.73%-7.72M5.41%-8.36M-68.42%-9.93M-56.71%-7.3M-55.63%-26.57M-40.36%-7.17M
Net non-operating interest income expense 374.25%162.8K89,293.80%115.32K176.02K729.47%124.51K964.72%104.02K3,465.49%34.33K-95.71%129-43.42%-13.97K-157.35%-19.78K-169.71%-12.03K
Non-operating interest income 338.59%162.92K3,268.59%116.05K--178.38K1,083.71%148.56K10,260.19%106.71K1,708.52%37.15K-63.61%3.45K--1.25K--12.55K--1.03K
Non-operating interest expense -95.67%122-77.99%730--2.35K-25.62%24.05K-79.38%2.69K-8.30%2.82K-48.67%3.32K56.30%15.22K320.63%32.33K192.80%13.06K
Other net income (expense) -137.75%-393.33K2,308.29%125.83K-111.58K-149.55%-582.62K-154.96%-12.52K-193.34%-165.44K-98.59%5.23K-167.78%-409.88K482.38%1.18M-94.46%22.79K
Gain on sale of security --810.9K--1.43M------------------------309.37%950.15K-96.95%13.9K
Earnings from equity interest -------------85.16%-415.75K100.00%-3--0--0-1,536.01%-415.74K14.58%-224.53K-184.11%-125.78K
Special income (charges) ---1.22M--0---6.73K------------------0--------
-Less:Restructuring and merger&acquisition --365.48K--0--6.73K------------------0--------
-Write off --857.11K------------------------------------
Other non- operating income (expenses) 111.10%18.37K-25,066.85%-1.3M---104.85K-137.06%-166.87K-109.30%-12.52K-15,119.60%-165.44K-98.35%5.23K--5.86K10.06%450.31K--134.67K
Income before tax 78.55%-1.82M65.27%-3.45M-4.09M-32.93%-33.78M-6.61%-7.63M1.98%-8.49M-79.73%-9.92M-90.06%-7.73M-46.16%-25.41M-52.28%-7.16M
Income tax
Net income 78.55%-1.82M65.27%-3.45M-4.09M-32.93%-33.78M-6.61%-7.63M1.98%-8.49M-79.73%-9.92M-90.06%-7.73M-46.16%-25.41M-52.28%-7.16M
Net income continuous Operations 78.55%-1.82M65.27%-3.45M---4.09M-32.93%-33.78M-6.61%-7.63M1.98%-8.49M-79.73%-9.92M-90.06%-7.73M-46.16%-25.41M-52.28%-7.16M
Minority interest income
Net income attributable to the parent company 78.55%-1.82M65.27%-3.45M-4.09M-32.93%-33.78M-6.61%-7.63M1.98%-8.49M-79.73%-9.92M-90.06%-7.73M-46.16%-25.41M-52.28%-7.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 78.55%-1.82M65.27%-3.45M-4.09M-32.93%-33.78M-6.61%-7.63M1.98%-8.49M-79.73%-9.92M-90.06%-7.73M-46.16%-25.41M-52.28%-7.16M
Basic earnings per share 87.31%-0.6666.00%-2.04-2.4-11.83%-20.8-14.29%-4.810.34%-5.2-25.00%-6-33.33%-4.8-4.49%-18.6-5.00%-4.2
Diluted earnings per share 87.31%-0.6666.00%-2.04-2.4-11.83%-20.8-14.29%-4.810.34%-5.2-25.00%-6-33.33%-4.8-4.49%-18.6-5.00%-4.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg